首页> 美国卫生研究院文献>International Journal of Nanomedicine >Polyethylenimine-based microanoparticles as vaccine adjuvants
【2h】

Polyethylenimine-based microanoparticles as vaccine adjuvants

机译:基于聚乙烯亚胺的微米/纳米颗粒作为疫苗佐剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vaccines have shown great success in treating and preventing tumors and infections, while adjuvants are always demanded to ensure potent immune responses. Polyethylenimine (PEI), as one of the well-studied cationic polymers, has been used as a transfection reagent for decades. However, increasing evidence has shown that PEI-based particles are also capable of acting as adjuvants. In this paper, we briefly review the physicochemical properties and the broad applications of PEI in different fields, and elaborate on the intracellular processes of PEI-based vaccines. In addition, we sum up the proof of their in vivo and clinical applications. We also highlight some mechanisms proposed for the intrinsic immunoactivation function of PEI, followed by the challenges and future perspectives of the applications of PEI in the vaccines, as well as some strategies to elicit the desirable immune responses.
机译:疫苗在治疗和预防肿瘤和感染方面已显示出巨大的成功,而始终需要佐剂来确保有效的免疫反应。聚乙烯亚胺(PEI),作为一种研究良好的阳离子聚合物,几十年来一直用作转染试剂。但是,越来越多的证据表明,基于PEI的颗粒也可以用作佐剂。在本文中,我们简要回顾了PEI在不同领域的理化特性和广泛应用,并详细阐述了基于PEI的疫苗的细胞内过程。另外,我们总结了它们在体内和临床上的应用证明。我们还重点介绍了针对PEI的固有免疫激活功能提出的一些机制,随后是PEI在疫苗中应用的挑战和未来展望,以及引发期望的免疫应答的一些策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号